Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05201612
Title Pembrolizumab and Olaparib in Homologous-recombination Deficient (HRD) Advanced Colorectal Cancer (CRC). (PEMBROLA)
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Grupo Espanol Multidisciplinario del Cancer Digestivo
Indications

colorectal cancer

Therapies

Olaparib + Pembrolizumab

Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.